COMPLIANCE WITH NATIONAL DATA PROTECTION LAWS Sample Clauses

COMPLIANCE WITH NATIONAL DATA PROTECTION LAWS. 3.1 Each Party must ensure compliance with applicable national data protection laws at all times during the Term. 3.2 Each Party has a valid registration with its national Data Protection Authority if required which, by the time that the data sharing is expected to commence, covers the intended data sharing pursuant to this Agreement. (a) University Registration Number Z5668803 (b) RUSU Registration Number Z6782306
Sample 1See All (5)
AutoNDA by SimpleDocs
COMPLIANCE WITH NATIONAL DATA PROTECTION LAWS. 3.1 Each of the Collective Parties confirms that it is and will continue to be compliant with the Data Protection Laws in force from time to time in respect of its Processing of Agreement Personal Data, at all times during the Term of the Agreement, and that, in respect of its Processing of Agreement Personal Data, it maintains a valid registration with its national Supervisory Authority, to the extent required by Data Protection Laws, including the payment of any applicable fees, which covers the Processing of the relevant Personal Data, including Agreement Personal Data. 3.2 Each of the Collective Parties confirms that it is responsible for ensuring that it is compliant with its own legal obligations imposed under Data Protection Laws, including maintaining and updating their own data protection policies and procedures to ensure that any Sharing or Processing of Agreement Personal Data is lawful. 3.3 Each of the Collective Parties, in its capacity as a Controller, confirms that it has implemented policies that:- 3.3.1 explain its procedures for securing compliance with the principles in Article 5 of the GDPR (principles relating to Processing of Personal Data) in connection with the Processing of Agreement Personal Data under this Agreement and Schedule; and 3.3.2 explain its policies as regards the retention and erasure of any Agreement Personal Data Processed, giving an indication of how long such Agreement Personal Data is likely to be retained.
Sample 1Sample 2Sample 3
COMPLIANCE WITH NATIONAL DATA PROTECTION LAWS. 5.1. Each Party must ensure compliance with applicable national data protection laws at all times during the Term. 5.2. Each Party has a valid registration with its national Data Protection Authority if required which, by the time that the data sharing is expected to commence, covers the intended data sharing pursuant to this Agreement.
Sample 1
COMPLIANCE WITH NATIONAL DATA PROTECTION LAWS. Each of the Collective Parties confirms that it is and will continue to be compliant with the Data Protection Laws in force from time to time in respect of its Processing of Agreement Personal Data, at all times during the Term of the Agreement, and that, in respect of its Processing of Agreement Personal Data, it maintains a valid registration with its national Supervisory Authority, to the extent required by Data Protection Laws, including the payment of any applicable fees, which covers the Processing of the relevant Personal Data, including Agreement Personal Data.
Sample 1Sample 2
COMPLIANCE WITH NATIONAL DATA PROTECTION LAWS. 3.1 Each Party must ensure compliance with applicable national data protection laws at all times during the Term. 3.2 Each Party has a valid registration with the Data Protection Authority if required which, by the time that the data sharing is expected to commence, covers the intended data sharing pursuant to this Agreement. IMI Registration Number Z5668803 [IMI Approved Centre Name] and [ICO Registration Number Z…………………….]
Sample 1
COMPLIANCE WITH NATIONAL DATA PROTECTION LAWS. 3.1 Each Party has a valid registration with the Information Commissioner’s Office, unless an exemption applies. 3.2 Before the Data Discloser shares any Shared Personal Data with the Data Receiver under this DS Agreement, the Data Discloser shall ensure that it has carried out a Data Protection Impact Assessment which thoroughly reviews the validity and justification of the proposed data sharing, including but not limited to the need for patients to be aware of how their Personal Data will be used, the proportionality of any Personal Data to be provided and the measures to be taken to keep such data secure. In the event that the Data Discloser does not consider that a Data Protection Impact Assessment is required in a particular instance, it shall keep a full written record of its reasons for taking this view. 3.3 The provisions of this DS Agreement shall not affect the generality of the requirements set out at clause 1.1 of Schedule 2.
Sample 1
COMPLIANCE WITH NATIONAL DATA PROTECTION LAWS. 3.1 Each Party must ensure compliance with applicable national data protection laws at all times during the Term. Each Party has a valid registration with the Data Protection Authority by the time the data sharing is expected to commence and this will cover the intended data sharing pursuant to this Agreement. (a) School Registration Number Z7044954 (b) LSESU Registration Number ZA106815
Sample 1
AutoNDA by SimpleDocs
COMPLIANCE WITH NATIONAL DATA PROTECTION LAWS. 3.1 Each party must ensure compliance with Privacy and Data Protection Requirements at all times during the Term of this Agreement. 3.2 For the purposes of the Privacy and Data Protection Requirements NAFN’s Data Protection Officer is Xxxxxx Xxxxxxx.
Sample 1
COMPLIANCE WITH NATIONAL DATA PROTECTION LAWS. Each Party must process the Shared Personal Data in compliance with applicable Data Protection Legislation at all times during the Term. In the event that the applicable data protection law of each Party conflict, the requirements of the country that necessitates stricter or additional requirements to protect individuals’ privacy and personal data shall be applied.
Sample 1

Related to COMPLIANCE WITH NATIONAL DATA PROTECTION LAWS

  • Compliance with Data Protection Laws 2.1 bookinglab shall comply with its obligations under the Data Protection Laws as they apply to it as a Data Processor of the Customer Personal Data. 2.2 The Customer shall comply with its obligations under the Data Protection Laws as they apply to it as a Data Controller of the Customer Personal Data.

  • Certification of Compliance with the Energy Policy and Conservation Act When appropriate and to the extent consistent with the law, Vendor certifies that it will comply with the Energy Policy and Conservation Act (42 U.S.C. 6321 et seq; 49 C.F.R. Part 18) and any mandatory standards and policies relating to energy efficiency which are contained in applicable state energy conservation plans issued in compliance with the Act. Does Vendor agree? Yes

  • Compliance with Anti-Corruption Laws Neither the Company nor any of its Controlled Entities or their respective affiliates, nor any director, officer or employee thereof nor, to the Company’s knowledge, any agent or representative of the Company or of any of its Controlled Entities or their respective affiliates, has (i) used any corporate funds for any unlawful contribution, gift, entertainment or other unlawful expense relating to political activity; (ii) taken or will take any action in furtherance of an offer, payment, promise to pay, or authorization or approval of the payment, giving or receipt of money, property, gifts or anything else of value, directly or indirectly, to any “government official” (including any officer, director or employee of a government or government-owned or controlled entity or of a public international organization, or any person acting in an official capacity for or on behalf of any of the foregoing, or any political party or party official or candidate for political office) to induce such government official to do or omit to do any act in violation of his lawful duties, influence official action or secure, obtain or retain business or any other improper advantage; (iii) made, offered, agreed, requested or taken an act in furtherance of any unlawful bribe or other unlawful benefit, including, without limitation, any rebate, payoff, influence payment, kickback or other unlawful or improper payment or benefit; or (iv) will use, directly or indirectly, the proceeds of the offering in furtherance of an offer, payment, promise to pay, or authorization of the payment or giving of money, or anything else of value, to any person in violation of any applicable anti-bribery or anti-corruption laws, in each case as amended from time to time, (collectively, the “Anti-Corruption Laws”); and the Company and its Controlled Entities and affiliates have conducted their businesses in compliance with Anti-Corruption Laws and have instituted, maintained and enforced, and will continue to maintain and enforce, policies and procedures reasonably designed to promote and achieve compliance with such laws and with the representations and warranties contained herein; no investigation, action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any of its Controlled Entities with respect to the Anti-Corruption Laws is pending or, to the best knowledge of the Company after due and careful inquiry, threatened.

  • Compliance with Anti-Corruption Laws and Sanctions Maintain in effect and enforce policies and procedures designed to ensure compliance by the Borrower, its Subsidiaries and their respective directors, officers, employees and agents with Anti-Corruption Laws and applicable Sanctions.

  • Compliance with Health Care Laws Each of the Company and its Subsidiaries is, and at all times has been, in compliance in all material respects with all applicable Health Care Laws, and has not engaged in activities which are, as applicable, cause for false claims liability, civil penalties, or mandatory or permissive exclusion from Medicare, Medicaid, or any other state or federal health care program. For purposes of this Agreement, “Health Care Laws” means: (i) the Federal Food, Drug, and Cosmetic Act (21 U.S.C. §§ 301 et seq.), the Public Health Service Act (42 U.S.C. §§ 201 et seq.), and the regulations promulgated thereunder; (ii) all applicable federal, state, local and all applicable foreign health care related fraud and abuse laws, including, without limitation, the U.S. Anti-Kickback Statute (42 U.S.C. Section 1320a-7b(b)), the U.S. Physician Payment Sunshine Act (42 U.S.C. § 1320a-7h), the U.S. Civil False Claims Act (31 U.S.C. Section 3729 et seq.), the criminal False Claims Law (42 U.S.C. § 1320a-7b(a)), all criminal laws relating to health care fraud and abuse, including but not limited to 18 U.S.C. Sections 286 and 287, and the health care fraud criminal provisions under the U.S. Health Insurance Portability and Accountability Act of 1996 (“HIPAA”) (42 U.S.C. Section 1320d et seq.), the exclusion laws (42 U.S.C. § 1320a-7), the civil monetary penalties law (42 U.S.C. § 1320a-7a), HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act (42 U.S.C. Section 17921 et seq.), and the regulations promulgated pursuant to such statutes; (iii) Medicare (Title XVIII of the Social Security Act); (iv) Medicaid (Title XIX of the Social Security Act); (v) the Controlled Substances Act (21 U.S.C. §§ 801 et seq.) and the regulations promulgated thereunder; and (vi) any and all other applicable health care laws and regulations. Neither the Company nor, to the knowledge of the Company, any subsidiary has received notice of any claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration or other action from any court or arbitrator or governmental or regulatory authority or third party alleging that any product operation or activity is in material violation of any Health Care Laws, and, to the Company’s knowledge, no such claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration or other action is threatened. Neither the Company nor, to the knowledge of the Company, any subsidiary is a party to or has any ongoing reporting obligations pursuant to any corporate integrity agreements, deferred prosecution agreements, monitoring agreements, consent decrees, settlement orders, plans of correction or similar agreements with or imposed by any governmental or regulatory authority. Additionally, neither the Company, its Subsidiaries nor any of its respective employees, officers or directors has been excluded, suspended or debarred from participation in any U.S. federal health care program or human clinical research or, to the knowledge of the Company, is subject to a governmental inquiry, investigation, proceeding, or other similar action that could reasonably be expected to result in debarment, suspension, or exclusion.

  • Compliance with Federal Law, Regulations, and Executive Orders This is an acknowledgement that FEMA financial assistance will be used to fund all or a portion of the contract. The contractor will comply with all applicable Federal law, regulations, executive orders, FEMA policies, procedures, and directives.

  • Compliance with Healthcare Laws The tests, studies, and trials conducted by or on behalf of or sponsored by the Company or any of its subsidiaries were and, if still pending, are being conducted in all material respects in accordance with all applicable Health Care Laws (as defined below) and standard medical and scientific research protocols, procedures, and controls; none of the Company or any of its subsidiaries has received any written notice, correspondence, or other written communication from any regulatory agency or any institutional review board or comparable body requiring or threatening the termination, suspension, or material modification of any tests, studies, or trials, or commercial distribution, and to the knowledge of the Company and its subsidiaries, there are no reasonable grounds for the same. Each of the Company and its Subsidiaries has obtained (or caused to be obtained) the informed consent of each human subject who participated in a test, study, or trial. None of the tests, studies, or trials involved any investigator who has been disqualified as a clinical investigator. The Company and its directors, officers, employees, and agents are, and at all times prior hereto have been, in material compliance with, all health care laws and regulations applicable to the Company or any of its product candidates or activities, including development and testing of pharmaceutical products, kickbacks, recordkeeping, documentation requirements, the hiring of employees (to the extent governed by Health Care Laws), quality, safety, privacy, security, licensure, accreditation or any other aspect of developing and testing health care or pharmaceutical products (collectively, “Health Care Laws”). The Company has not received any notification, correspondence or any other written or oral communication, including notification of any pending or threatened claim, suit, proceeding, hearing, enforcement, investigation, arbitration or other action from any governmental authority, including, without limitation, the United States Food and Drug Administration, the Drug Enforcement Agency, the Centers for Medicare & Medicaid Services, and the U.S. Department of Health and Human Services Office of Inspector General, of potential or actual non-compliance by, or liability of, the Company under any Health Care Laws. To the Company’s knowledge, there are no facts or circumstances that would reasonably be expected to give rise to liability of the Company under any Health Care Laws, except that would not individually or in the aggregate have a Material Adverse Effect.

  • Compliance with Statutes Rules and Regulations

  • Compliance with Texas Privacy Laws and Regulations In performing their respective obligations under the Agreement, the LEA and the Provider shall comply with all Texas laws and regulations pertaining to LEA data privacy and confidentiality, including but not limited to the Texas Education Code Chapter 32, and Texas Government Code Chapter 560.

  • Compliance with Statutes, Regulations, Etc The Borrower will, and will cause each Subsidiary to, comply with all applicable laws, rules, regulations and orders applicable to it or its property, including all governmental approvals or authorizations required to conduct its business, and to maintain all such governmental approvals or authorizations in full force and effect, in each case except where the failure to do so could not reasonably be expected to have a Material Adverse Effect.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!